Hyperforin Suppresses Oncogenic Kinases and Induces Apoptosis in Colorectal Cancer Cells

Li-Cho Hsu1, Chen-Yu Kuo2, Fei-Ting Hsu3

  • 1Department of Medicine, National Yang-Ming Chiao-Tung University Hospital, Yilan, Taiwan, R.O.C.

In Vivo (Athens, Greece)
|January 2, 2023
PubMed
Abstract

Insights

Hyperforin, derived from Hypericum perforatum, effectively suppresses colorectal cancer (CRC) progression by inhibiting key signaling pathways like JAK/STAT3, ERK, and AKT, while also inducing cancer cell death.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Signal transducer and activator of transcription 3 (STAT3), Janus Kinase 1 (JAK1), extracellular signal-regulated kinase (ERK), and protein kinase B (AKT) are crucial for colorectal cancer (CRC) development.
  • Hyperforin, a compound from Hypericum perforatum, is known for anti-inflammatory properties, but its effect on CRC signaling pathways was unexplored.

Purpose of the Study:

  • To investigate the efficacy of hyperforin in suppressing colorectal cancer (CRC) progression.
  • To elucidate the molecular mechanisms by which hyperforin affects CRC, specifically targeting JAK/STAT3, ERK, and AKT signaling pathways.

Main Methods:

  • Human colorectal cancer (CRC) cells were utilized to assess hyperforin's effects.
  • Standard assays including MTT, flow cytometry, wound healing, and western blotting were employed to determine treatment efficacy and mechanisms.

Main Results:

  • Hyperforin demonstrated significant cytotoxicity against CRC cells.
  • The compound inhibited CRC cell invasion and migration.
  • Hyperforin reduced the phosphorylation of key signaling proteins: STAT3, JAK1, ERK, and AKT.

Conclusions:

  • Hyperforin effectively inactivates multiple oncogenic kinase pathways implicated in CRC.
  • The study concludes that hyperforin induces apoptosis signaling in colorectal cancer cells, suggesting its therapeutic potential.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K